Anika Therapeutics' GAAP net income for 2021 was $4.134 million, compared to a loss of $23.982 million in the previous year. Revenue increased by 13.3% to $147.794 million from $130.457 million a year earlier.
Anika Therapeutics' GAAP net income for 2021 was $4.134 million, compared to a loss of $23.982 million in the previous year. Revenue increased by 13.3% to $147.794 million from $130.457 million a year earlier. 
ir.anikatherapeutics.com
English (US) 